Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(603)
•••
Post by subaru1ion Apr 19, 2024 12:52pm
79 Views
Post# 35998302

CBN and LABS update....

CBN and LABS update....

What is CBN? Lesser-known cannabis compound may protect brain cells

APRIL 18, 2024


LA JOLLA, Calif. — When it comes to cannabinoids — compounds found in the cannabis plant — THC and CBD usually get all the attention. However, CBN (cannabinol), a lesser-known cannabinoid, is showing serious promise as a means of fending off neurodegeneration in the aging brain.

The milder, less psychoactive cannabinoid displayed neuroprotective properties among fruit flies. Moreover, researchers from the  Salk Institute have identified cannabinol compounds that may one day serve as promising future therapeutics for conditions including traumatic brain injury, Alzheimer’s, and Parkinson’s disease.




About the product
This CBN 1:2 Nighttime High-CBN Formula Oil from MediPharm Labs is made with refined CBN material. Each 30 mL bottle contains 300mg of CBN and 600mg of THC. It has a concentration of 20 mg/mL of THC and 10 mg/mL of CBN per millilitre.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities